KD Logo

InMed Pharmaceuticals Inc’s latest rating changes from various analysts

InMed Pharmaceuticals Inc’s recently made public that its Consultant MANCINI ALEXANDRA DIANE JANET unloaded Company’s shares for reported $42.0 on Jul 31 ’24. In the deal valued at $0.18 per share,240 shares were sold. As a result of this transaction, MANCINI ALEXANDRA DIANE JANET now holds 0 shares worth roughly $0.0.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, HULL ANDREW bought 37,500 shares, generating $14,625 in total proceeds. Upon buying the shares at $0.39, the Director now owns 38,258 shares.

Before that, ADAMS ERIC A bought 41,600 shares. InMed Pharmaceuticals Inc shares valued at $14,922 were divested by the President & CEO at a price of $0.36 per share. As a result of the transaction, ADAMS ERIC A now holds 43,959 shares, worth roughly $12748.109999999999.

Price Performance Review of INM

On Monday, InMed Pharmaceuticals Inc [NASDAQ:INM] saw its stock jump 21.04% to $0.29. Over the last five days, the stock has gained 40.10%. InMed Pharmaceuticals Inc shares have fallen nearly -30.29% since the year began. Nevertheless, the stocks have fallen -51.67% over the past one year. While a 52-week high of $2.08 was reached on 08/20/24, a 52-week low of $0.12 was recorded on 08/06/24. SMA at 50 days reached $0.2591, while 200 days put it at $0.2945.

Levels Of Support And Resistance For INM Stock

The 24-hour chart illustrates a support level at 0.2287, which if violated will result in even more drops to 0.1675. On the upside, there is a resistance level at 0.3506. A further resistance level may holdings at 0.4113. The Relative Strength Index (RSI) on the 14-day chart is 64.95, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0363, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 37.97%. Stochastics %K at 75.40% indicates the stock is a holding.

How much short interest is there in InMed Pharmaceuticals Inc?

A steep rise in short interest was recorded in InMed Pharmaceuticals Inc stocks on 2024-09-30, dropping by -0.25 million shares to a total of 93164.0 shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 0.34 million shares. There was a decline of -269.81%, which implies that there is a negative sentiment for the stock.

Most Popular